Reishi Mushroom Benefits: What the Research Actually Shows

By Peter Orpen, Co-Owner, Teelixir

Most articles get reishi wrong. Here's what the research actually shows.

There's a version of reishi you've probably seen — the one where it is claimed to have extraordinary traditional benefits. That version is marketing copy, not science.

There's also an overly sceptical version: "no credible evidence exists". That version ignores five human randomised controlled trials, two Cochrane systematic reviews, and a 2025 meta-analysis of 17 RCTs involving 971 participants.

The truth sits between those two stories. Reishi has genuine, peer-reviewed evidence for specific outcomes. It also has significant gaps, mixed results in cardiovascular studies, and real drug interaction concerns that most supplement articles don't mention.

This article covers what the research actually shows — including the negative findings.

What is reishi mushroom?

Reishi (Ganoderma lucidum, known in Chinese as líng zhī) is a woody mushroom used in traditional East Asian medicine for more than 2,000 years. It appears in the Shen Nong Ben Cao Jing — the oldest surviving Chinese herbal compendium — classified in the highest tier of tonics for "nourishing life" (PMID: 32325828).

The mushroom contains two primary classes of bioactive compounds:

• Polysaccharides (including beta-glucans) — high-molecular-weight structures that interact with immune receptors, particularly Dectin-1 on macrophages (PMID: 40592243)
• Triterpenoids (ganoderic acids) — bitter-tasting compounds studied for anti-inflammatory, antioxidant, and potential anti-tumour properties in preclinical models (PMID: 39450753)

A 2025 review confirmed that the pharmacological effects of these compounds depend substantially on how the mushroom is extracted — structure-activity relationships vary significantly by extraction method (PMID: 40719895). This is why processing matters.

"High-molecular-weight beta-glucans activate macrophages via Dectin-1 receptors through triple-helix conformations. Sulfation enhances immune cell interactions." — 2025 systematic review, PMID: 40592243

The strongest human evidence: what reishi actually does

1. Traditionally used to support immune health

The most consistent human evidence for reishi relates to immune function modulation — specifically, natural killer (NK) cells and T-lymphocytes may be influenced.

In a 2007 double-blind RCT of 16 healthy volunteers receiving 2g Ganoderma lucidum extract twice daily for 10 days, CD56-positive NK cell counts trended upward during supplementation and returned to baseline after stopping (PMID: 17597499). No adverse effects were observed across ECG, complete blood counts, blood chemistry, or urinalysis — confirming general safety at doses used in studies.

A 2021 systematic review of Chinese herbal medicines found reishi consistently among herbs that modulate NK cell numbers and cytotoxicity in cancer patients (PMID: 33157222). The 2025 mechanistic review confirmed that beta-glucan triple-helix conformation is critical to this receptor activation (PMID: 40592243).

A 2021 systematic review of fungal beta-glucan RCTs found evidence for immune modulation and prebiotic effects — though it noted significant heterogeneity across trials. Effects varied by glucan source, structure, and dose (PMID: 33876798).

The honest picture: Reishi has been traditionally used to support immune health in wellness practices. Most studies on the mechanism were animal or in vitro. The human RCT data shows promise but is based on small samples.

2. Fatigue and stress

The most rigorous human fatigue trial remains a 2005 double-blind RCT of 132 patients with neurasthenia — a condition characterised by persistent fatigue, anxiety, and low energy (PMID: 15857210). Participants received Ganopoly (Ganoderma lucidum polysaccharide extract at 1,800mg three times per day) or placebo for 8 weeks.

Results: CGI severity score reduced by 15.5%, sense of fatigue improved by 28.3%, and well-being scores improved by 38.7% in the reishi group versus 29.7% in placebo. 51.6% were rated "more than minimally improved" vs 24.6% on placebo — a clinically meaningful separation.

These results should be interpreted with appropriate caution: neurasthenia is a specific diagnostic category, doses used in this study were high (5,400mg/day), and replication in other populations is limited. But this is one of the more methodologically sound positive trials in the reishi literature.

3. Urinary tract symptoms in older men

This is one of the least-hyped but most robustly positive findings in the reishi literature.

A 2008 double-blind RCT enrolled 88 men aged 49 and over with mild-to-moderate lower urinary tract symptoms (LUTS) (PMID: 18097505). Participants received 6mg/day Ganoderma lucidum extract or placebo for 12 weeks. Total IPSS (International Prostate Symptom Score) decreased by a mean of 2.1 points in the reishi group versus placebo (p<0.0001). No severe adverse effects were reported.

A 2.1-point reduction on IPSS is modest by clinical standards, but statistically significant and consistent with the therapeutic threshold for meaningful symptom relief. This trial is underreported in supplement circles, possibly because it doesn't fit the "immune superfood" narrative.

4. Adjunct support in cancer care

This is the area that generates the most misinformation — in both directions.

Two Cochrane systematic reviews (2012 and 2016) assessed reishi as an adjunct cancer treatment. Their conclusion was carefully worded: patients who used reishi alongside conventional treatment showed better quality of life scores and enhanced immune response including stimulated T-cells and NK cells (PMID: 22696372, PMID: 27045603).

However — and this is critical — neither Cochrane review concluded that reishi demonstrated efficacy as a standalone cancer treatment. The 2016 update maintained the same conclusion as 2012. Evidence quality was rated as low.

What the evidence does not show: reishi did not demonstrate the ability to shrink tumours, prevent metastasis, or replace conventional cancer treatment in any of these trials.

A 2020 systematic review raised an additional concern: reishi may affect drug metabolism via CYP enzyme pathways, with potential pharmacokinetic interactions with cytotoxic cancer drugs (PMID: 32724333). Anyone undergoing cancer treatment should discuss reishi use with their oncologist before starting.

5. Metabolic markers: BMI and blood glucose

The most recent and methodologically strongest metabolic evidence comes from a 2025 GRADE-assessed systematic review and meta-analysis of 17 RCTs involving 971 participants (PMID: 40510787). Reishi supplementation (doses ranging from 200–11,200mg/day, duration 1–24 weeks) showed statistically significant reductions in body mass index and fasting blood glucose.

No consistent effects were found on other metabolic markers, including blood pressure, total cholesterol, or insulin resistance. This aligns with the 2015 Cochrane review of cardiovascular risk factors, which found no significant effects on blood pressure, blood glucose, or BMI — though quality of evidence was rated very low (PMID: 25686270).

The 2025 GRADE meta-analysis is more recent and methodologically stronger. The BMI and fasting glucose findings are the more credible evidence for metabolic effects at doses used in studies.

The evidence gaps — what reishi does NOT reliably do

Honesty about limitations is part of how you evaluate a supplement, not a reason to dismiss it.

Cardiovascular risk factors

The 2015 Cochrane review (five RCTs) found no significant effects on blood pressure, blood glucose, or BMI (PMID: 25686270). Some evidence existed for lipid-lowering effects, but quality of evidence was rated very low. Animal studies show more consistent lipid effects — a 2023 meta-analysis of animal studies found significant reductions in total cholesterol, LDL, and triglycerides (PMID: 38116485) — but these findings did not demonstrate consistently in human trials.

Cognition

A 2026 systematic review of phytochemical compounds for cognition included reishi among many compounds but found limited reishi-specific cognitive conclusions (PMID: 41575193). Two systematic review protocols for Ganoderma spore powder effects on cognition in neurodegenerative conditions remain unpublished (PMID: 30702632, PMID: 32872049). The cognitive evidence base for reishi is currently a gap rather than a strength.

Rheumatoid arthritis — a nuanced finding

A 2007 24-week double-blind RCT of 65 patients with active rheumatoid arthritis (4g/day) showed significant improvement in pain score and patient global score versus placebo (PMID: 17907228). However, the same study found no significant changes in antioxidant markers or major effects on immune markers. The pain improvement without corresponding inflammatory marker changes is an unusual finding that has not been fully explained.

Traditional uses and mechanisms (mostly preclinical)

A 2026 systematic review and meta-analysis of Ganoderma triterpene effects noted traditional uses and pathways — but emphasised that evidence was preclinical only (in vitro and animal studies 2003–2025) (PMID: 41599785). The triterpenoid anti-inflammatory effects visible in cell studies have not yet demonstrated consistently in human clinical trials.

The Compound Complexity Problem — why extraction method matters

This is the concept that explains most of the conflicting reishi literature. Call it The Extraction Variable.

A 2025 review of polysaccharide extraction methods made this explicit: pharmacological effects depend substantially on extraction conditions, with structure-activity relationships varying by method (PMID: 40719895). Different trials use different preparations — whole food powder, hot water extracts, ethanol extracts, spore powder, isolated polysaccharides. These are not interchangeable products, and yet they are often lumped into "reishi studies" as if they were.

The triterpenoid research adds another layer. Ganoderic acids are better extracted via ethanol (they are not water-soluble). Polysaccharides require hot water extraction. A whole food powder retains both compound classes at natural ratios, without concentrating either. Neither approach is objectively superior — they represent different trade-offs.

What this means: when you read "a study found reishi did X", the preparation used matters enormously. A hot water extract trial cannot be directly applied to a whole food powder, and vice versa.

Should you take reishi? Evidence-based decision guide

Your situation	Evidence verdict	Notes
You want immune support during high-stress periods	Supported	NK cell modulation shown in human studies. RCT and systematic review evidence.
You have persistent fatigue	Supported with caveats	One large RCT (n=132) showed significant fatigue reduction. Dose: 1,800mg 3x/day. Consult your healthcare professional to rule out other causes.
You are a man aged 49+ with urinary tract symptoms	Supported	12-week RCT (n=88) showed significant IPSS improvement (p<0.0001). Dose: 6mg extract/day.
You are managing high blood pressure	Insufficient evidence	Cochrane review found no significant effects on blood pressure. Do not use as substitute for prescribed medication.
You are undergoing cancer treatment	Consult oncologist first	Drug interactions via CYP enzymes documented. May support quality of life alongside treatment but must be discussed with your oncologist.
You are taking prescription medications	Medical advice required	CYP enzyme interactions documented. Not appropriate without healthcare professional guidance.
You want cognitive enhancement	Insufficient evidence	Limited reishi-specific cognitive data. Evidence gap, not a strength.
You are pregnant or breastfeeding	Not recommended	Insufficient safety data. Avoid if pregnant or breastfeeding without medical advice.

Safety — what the research shows

Reishi has one of the better safety profiles in the medicinal mushroom literature.

In a rigorous 2007 RCT, 16 healthy volunteers received 4g Ganoderma lucidum extract daily for 10 days. No adverse effects were observed across ECG, complete blood counts, blood chemistry, or urinalysis versus placebo (PMID: 17597499). A 2023 systematic review of Ganoderma spore extract confirmed the pattern: generally well-tolerated, with no serious adverse events reported across included studies (PMID: 37790044).

Minor reported adverse effects in longer trials include mild GI disturbance and occasional skin reactions, but these were infrequent and typically resolved without intervention.

The primary safety concern is drug interaction. A 2020 systematic review identified potential pharmacokinetic interactions between reishi and cytotoxic drugs via CYP enzyme pathways (PMID: 32724333). This is not a hypothetical risk — it is documented in the literature. Anyone on prescription medications should speak to their doctor before adding reishi.

Reishi is also not suitable if you are pregnant or breastfeeding, and is not recommended for children without medical supervision.

What this means in practice

If you are considering reishi for immune support during high-demand periods, the evidence is reasonably supportive at doses used in studies. Start with 1–2g of whole food powder per day and aim for 4–6 weeks of consistent use before assessing effects.

You should consider combining reishi with a foundation of quality sleep, stress management, and a nutrient-dense diet — the evidence for reishi's traditional use in supporting general wellbeing operates alongside these fundamentals, not instead of them.

Try starting with a lower dose if you are new to medicinal mushrooms. Some people begin with 500mg–1g and increase gradually. The fatigue RCT used 5,400mg/day — a dose that would be unusual for a healthy person without clinical guidance.

There are situations where reishi is unlikely to help based on current evidence: you should not expect meaningful cognitive enhancement, blood pressure reduction, or cancer prevention from reishi alone. The evidence does not support those expectations.

Pair reishi with a consideration of your broader goals. It may work well alongside lion's mane for cognitive-immune combination stacking, though no head-to-head trial comparing the two exists.

When not to use reishi without professional guidance: if you are on any prescription medication, undergoing chemotherapy, managing a diagnosed immune condition, or pregnant. These are not suitable for self-directed supplementation.

From our formulations

Teelixir's Organic Reishi Mushroom uses a 1:1 whole food powder — meaning 1kg of fresh reishi mushroom yields 1kg of powder, with no extraction concentration applied. This preserves the full spectrum of naturally occurring polysaccharides, triterpenoids, and secondary compounds at the ratios found in the mushroom itself.

Our Teelixir Organic Whole Food Pure Reishi is ACO (Australian Certified Organic) certified. It is grown and processed without synthetic pesticides or fertilisers, third-party tested for heavy metals and microbial contamination, and sourced from certified cultivation operations.

A note on what we observe: the 2025 review that highlighted structure-activity relationships in polysaccharide extraction (PMID: 40719895) underscores why we favour whole food formulations for customers who want the full complement of reishi compounds without the trade-offs of extraction. Concentrated extracts are not inherently better — they optimise for specific compound classes at the expense of others. The right choice depends on your goals.

Frequently asked questions

What are the researched benefits of reishi mushroom?

The strongest human evidence supports reishi may help support immune modulation (NK cell activity, T-cell stimulation), fatigue reduction, and urinary tract symptom relief. A 2025 meta-analysis of 17 RCTs (n=971) also found significant reductions in BMI and fasting blood glucose. The research is more limited for traditional wellness applications in humans.

Is reishi mushroom traditionally used in wellness practices?

No. Two Cochrane reviews (2012 and 2016) found no trial demonstrated reishi as a standalone cancer treatment. The evidence suggests reishi may support general wellbeing when used alongside conventional approaches, but should never replace professional medical advice.

How much reishi mushroom should you take?

Doses used in human studies range from 1,800mg to 6,000mg daily. For whole food powder (1:1), a common starting dose is 1–2g per day. For concentrated extracts, doses are lower per gram due to higher compound concentration. Always consult your healthcare professional before starting supplementation, particularly if you are on prescription medication.

Is reishi mushroom safe?

Reishi has a strong safety record in clinical studies. A 2007 RCT confirmed no adverse effects at 4g/day for 10 days across comprehensive blood and cardiac markers. However, reishi may interact with prescription medications via CYP enzyme pathways. Consult your healthcare professional if you are on any prescription medication.

What is the difference between reishi extract and whole food reishi?

Extracted reishi concentrates specific compounds (polysaccharides or triterpenoids) to a higher potency per gram. Whole food powder (1:1) retains the full spectrum of compounds at natural concentrations. Both have demonstrated activity in studies. The 2025 extraction review (PMID: 40719895) found pharmacological effects depend on the extraction method used — they are not equivalent products.

Can you take reishi with other mushroom supplements?

No head-to-head stacking trials exist. However, reishi and lion's mane are commonly combined — reishi may help support immune modulation and lion's mane may help support nerve growth factor and cognition. Start with each individually before combining, and aim for consistency over 4–6 weeks to assess effects. Always consult your healthcare professional if you are on any medication.

If you found this useful, you may also want to read our evidence reviews on lion's mane mushroom benefits and chaga vs reishi: key differences. For a deeper understanding of how we evaluate evidence for our formulations, visit our approach to the science.

---

TGA Disclaimer: This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease or health condition. Teelixir products are food supplements and are not medicine. Always consult your healthcare professional before starting any new supplement, particularly if you have an existing medical condition, are taking prescription medications, are pregnant, or are breastfeeding.

Evidence disclaimer: Study findings cited in this article represent the current state of published research and do not constitute medical advice. Individual results vary. Most mechanistic studies are preclinical (animal or in vitro) and may not directly translate to human outcomes.